Detected ·
Khartis Therapeutics, Inc.
$95M—
Khartis Therapeutics, Inc. emerges from stealth with $95M in funding to advance a pipeline of oral small molecule medicines for immunological disease, including the first oral, selective IGF-1R inhibitor for thyroid eye disease.
- Website
- —
- Amount
- $95 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-08-14 08:04:05 UTC
- Signal ID
- 6e5c52a2-38e6-4e2c-8794-5dbaee502ddb
As the API returns it
{
"id": "6e5c52a2-38e6-4e2c-8794-5dbaee502ddb",
"created_at": "2026-08-14T08:04:05.606221Z",
"company_name": "Khartis Therapeutics, Inc.",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/khartis-therapeutics-inc",
"event_type": "funding",
"funding_amount": 95000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Khartis Therapeutics, Inc. emerges from stealth with $95M in funding to advance a pipeline of oral small molecule medicines for immunological disease, including the first oral, selective IGF-1R inhibitor for thyroid eye disease.*"
}